05
Jul
Source: RareDr.com
The interim results for the I-WISh survey undertaken by Novartis, which collaborated with 480 health care providers across 13 countries, found that a high percentage of patients with Immune Thrombocytopenia experienced negative impacts to their quality of life due to the immune disease.
05
May
Source: PDSA.org
At the end of March 2018, more than 30 people travelled from across the country to attend the first PDSA Regional Meeting in Melbourne, Victoria.